Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Estelle R Simons

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
American Journal of Respiratory and Critical Care Medicine|June 9, 2007
Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in miceYanbing Ma, Kent T HayGlass, Allan B Becker, et al.
The Journal of Allergy and Clinical Immunology|October 23, 2013
Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United StatesRobert A Wood, Carlos A Camargo, Philip Lieberman, et al.
The Journal of Allergy and Clinical Immunology|January 12, 2015
Anaphylaxis in America: A national physician surveyAshley M Altman, Carlos A Camargo, F Estelle R Simons, et al.
The Journal of Allergy and Clinical Immunology|March 8, 2011
World Allergy Organization anaphylaxis guidelines: summaryF Estelle R Simons, Ledit R F Ardusso, M Beatrice Bilò, et al.
The World Allergy Organization Journal|December 27, 2012
World allergy organization guidelines for the assessment and management of anaphylaxisF Estelle R Simons, Ledit R F Ardusso, M Beatrice Bilò, et al.
The World Allergy Organization Journal|November 4, 2015
2015 update of the evidence base: World Allergy Organization anaphylaxis guidelinesF Estelle R Simons, Motohiro Ebisawa, Mario Sanchez-Borges, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2009
Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) studyTmirah Haselkorn, James E Fish, Robert S Zeiger, et al.
International Archives of Allergy and Immunology|September 7, 2013
World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence baseF Estelle R Simons, Ledit R F Ardusso, Vesselin Dimov, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 11, 2018
Critical view of anaphylaxis epidemiology: open questions and new perspectivesLuciana Kase Tanno, Ana Luiza Bierrenbach, F Estelle R Simons, et al.
Current Respiratory Care Reports|November 9, 2012
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohortBradley E Chipps, Robert S Zeiger, Alejandro Dorenbaum, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
American Journal of Respiratory and Critical Care Medicine|June 9, 2007
Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in miceYanbing Ma, Kent T HayGlass, Allan B Becker, et al.
The Journal of Allergy and Clinical Immunology|October 23, 2013
Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United StatesRobert A Wood, Carlos A Camargo, Philip Lieberman, et al.
The Journal of Allergy and Clinical Immunology|January 12, 2015
Anaphylaxis in America: A national physician surveyAshley M Altman, Carlos A Camargo, F Estelle R Simons, et al.
The Journal of Allergy and Clinical Immunology|March 8, 2011
World Allergy Organization anaphylaxis guidelines: summaryF Estelle R Simons, Ledit R F Ardusso, M Beatrice Bilò, et al.
The World Allergy Organization Journal|December 27, 2012
World allergy organization guidelines for the assessment and management of anaphylaxisF Estelle R Simons, Ledit R F Ardusso, M Beatrice Bilò, et al.
The World Allergy Organization Journal|November 4, 2015
2015 update of the evidence base: World Allergy Organization anaphylaxis guidelinesF Estelle R Simons, Motohiro Ebisawa, Mario Sanchez-Borges, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2009
Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) studyTmirah Haselkorn, James E Fish, Robert S Zeiger, et al.
International Archives of Allergy and Immunology|September 7, 2013
World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence baseF Estelle R Simons, Ledit R F Ardusso, Vesselin Dimov, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 11, 2018
Critical view of anaphylaxis epidemiology: open questions and new perspectivesLuciana Kase Tanno, Ana Luiza Bierrenbach, F Estelle R Simons, et al.
Current Respiratory Care Reports|November 9, 2012
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohortBradley E Chipps, Robert S Zeiger, Alejandro Dorenbaum, et al.
Pageof 16